MAK Scientific LLC

Executive Summary

MAK Scientific LLC is a privately held contract research organization (CRO) and scientific consulting firm headquartered in Cambridge, Massachusetts. Founded in 2015, the company specializes in small molecule drug discovery, offering expertise in medicinal chemistry, computational chemistry, and project management to pharmaceutical and biotechnology partners. Its service-based business model positions it within the growing outsourced drug discovery market, which benefits from increasing R&D spending by biopharma companies seeking cost-effective and specialized external partners. MAK Scientific's focus on small molecules—a therapeutic modality with a strong track record—and its location in a major biotech hub provide access to top talent and potential clients. However, as a private company with no disclosed funding rounds or revenue figures, its financial performance and growth trajectory remain opaque. The competitive landscape includes numerous CROs, and the company's reliance on a limited number of clients could pose concentration risk. Nevertheless, its management's deep domain expertise and the steady demand for drug discovery services offer a baseline for stable operations.

Upcoming Catalysts (preview)

• Q4 2026Announcement of a multi-year contract with a top-20 pharmaceutical company40% success
• Q2 2027Launch of an expanded service line in targeted protein degradation (e.g., PROTACs)30% success
• TBDDisclosure of a strategic partnership for co-development of a lead asset15% success